Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load

Gang Huang(Shanghai Jiao Tong University), Mengchao Wu(Second Military Medical University), Wan Yee Lau(Chinese University of Hong Kong), Yuan Yang(Central South University), Siyuan Fu(Nanjing University of Posts and Telecommunications), Feng Shen(Second Military Medical University), Weiping Zhou(Second Military Medical University), Ze‐Ya Pan(Second Military Medical University)
Annals of Surgical Oncology
December 17, 2012
10.1245/s10434-012-2803-7
Cited by 41

Related Papers

Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
|PubMed|1999|519
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335